메뉴 건너뛰기




Volumn 168, Issue 1, 2013, Pages 189-199

Non-erythropoietic EPO protects kidney in I/R

Author keywords

apoptosis; Bcl 2; carbamylated; EPO; erythropoietin; glutaraldehyde erythropoietin; ischaemia reperfusion; JAK; kidney injury; non erythropoietic

Indexed keywords

ERYTHROPOIETIN RECEPTOR; GLUTARALDEHYDE ERYTHROPOIETIN; INTERLEUKIN 3 COMMON BETA RECEPTOR; INTERLEUKIN 3 RECEPTOR; JANUS KINASE 2 INHIBITOR; LYSINE; N BENZYL 2 CYANO 3 (3,4 DIHYDROXYPHENYL)ACRYLAMIDE; PROTEIN BCL 2; RECOMBINANT ERYTHROPOIETIN; UNCLASSIFIED DRUG; ERYTHROPOIETIN; JANUS KINASE 2; PROTECTIVE AGENT; RECOMBINANT PROTEIN;

EID: 84872851746     PISSN: 00071188     EISSN: 14765381     Source Type: Journal    
DOI: 10.1111/j.1476-5381.2012.02123.x     Document Type: Article
Times cited : (11)

References (62)
  • 1
    • 9644297877 scopus 로고    scopus 로고
    • Erythropoietin attenuates the tissue injury associated with hemorrhagic shock and myocardial ischemia
    • Abdelrahman M, Sharples EJ, McDonald MC, Collin M, Patel NS, Yaqoob MM, et al. (2004). Erythropoietin attenuates the tissue injury associated with hemorrhagic shock and myocardial ischemia. Shock 22: 63-69.
    • (2004) Shock , vol.22 , pp. 63-69
    • Abdelrahman, M.1    Sharples, E.J.2    McDonald, M.C.3    Collin, M.4    Patel, N.S.5    Yaqoob, M.M.6
  • 2
    • 4344626952 scopus 로고    scopus 로고
    • Low-dose therapy with the long-acting erythropoietin analogue darbepoetin alpha persistently activates endothelial Akt and attenuates progressive organ failure
    • Bahlmann FH, Song R, Boehm SM, Mengel M, von Waseljewski R, Lindschau C, et al. (2004). Low-dose therapy with the long-acting erythropoietin analogue darbepoetin alpha persistently activates endothelial Akt and attenuates progressive organ failure. Circulation 110: 1006-1012.
    • (2004) Circulation , vol.110 , pp. 1006-1012
    • Bahlmann, F.H.1    Song, R.2    Boehm, S.M.3    Mengel, M.4    Von Waseljewski, R.5    Lindschau, C.6
  • 3
    • 20044373442 scopus 로고    scopus 로고
    • Emerging biological roles for erythropoietin in the nervous system
    • Brines M, Cerami A, (2005). Emerging biological roles for erythropoietin in the nervous system. Nat Rev Neurosci 6: 484-494.
    • (2005) Nat Rev Neurosci , vol.6 , pp. 484-494
    • Brines, M.1    Cerami, A.2
  • 4
    • 33746137372 scopus 로고    scopus 로고
    • Discovering erythropoietin's extra-hematopoietic functions: Biological and clinical promise
    • Brines M, Cerami A, (2006). Discovering erythropoietin's extra-hematopoietic functions: biological and clinical promise. Kidney Int 70: 246-250.
    • (2006) Kidney Int , vol.70 , pp. 246-250
    • Brines, M.1    Cerami, A.2
  • 6
    • 6944237300 scopus 로고    scopus 로고
    • Erythropoietin mediates tissue protection through an erythropoietin and common β-subunit heteroreceptor
    • Brines M, Grasso G, Fiordaliso F, Sfacteria A, Ghezzi P, Fratelli M, et al. (2004). Erythropoietin mediates tissue protection through an erythropoietin and common β-subunit heteroreceptor. Proc Natl Acad Sci U S A 10: 14907-14912.
    • (2004) Proc Natl Acad Sci U S A , vol.10 , pp. 14907-14912
    • Brines, M.1    Grasso, G.2    Fiordaliso, F.3    Sfacteria, A.4    Ghezzi, P.5    Fratelli, M.6
  • 7
    • 0037447256 scopus 로고    scopus 로고
    • Recombinant human erythropoietin protects the myocardium from ischemia-reperfusion injury and promotes beneficial remodeling
    • Calvillo L, Latini R, Kajstura J, Leri A, Anversa P, Ghezzi P, et al. (2003). Recombinant human erythropoietin protects the myocardium from ischemia-reperfusion injury and promotes beneficial remodeling. Proc Natl Acad Sci U S A 100: 4802-4806.
    • (2003) Proc Natl Acad Sci U S A , vol.100 , pp. 4802-4806
    • Calvillo, L.1    Latini, R.2    Kajstura, J.3    Leri, A.4    Anversa, P.5    Ghezzi, P.6
  • 9
    • 7944222978 scopus 로고    scopus 로고
    • Science review: Recombinant human erythropoietin in critical illness: A role beyond anemia?
    • Coleman T, Brines M, (2004). Science review: recombinant human erythropoietin in critical illness: a role beyond anemia? Crit Care 8: 337-341.
    • (2004) Crit Care , vol.8 , pp. 337-341
    • Coleman, T.1    Brines, M.2
  • 10
    • 33645827977 scopus 로고    scopus 로고
    • Cytoprotective doses of erythropoietin or carbamylated erythropoietin have markedly different pro-coagulant and vasoactive activities
    • Coleman TR, Westenfelder C, Tögel FE, Yang Y, Hu Z, Swenson L, et al. (2006). Cytoprotective doses of erythropoietin or carbamylated erythropoietin have markedly different pro-coagulant and vasoactive activities. Proc Natl Acad Sci U S A 103: 5965-5970.
    • (2006) Proc Natl Acad Sci U S A , vol.103 , pp. 5965-5970
    • Coleman, T.R.1    Westenfelder, C.2    Tögel, F.E.3    Yang, Y.4    Hu, Z.5    Swenson, L.6
  • 11
    • 21444442363 scopus 로고    scopus 로고
    • Biosimilar epoetins: An analysis based on recently implemented European medicines evaluation agency guidelines on comparability of biopharmaceutical proteins
    • Combe C, Tredree RL, Schellekens H, (2005). Biosimilar epoetins: an analysis based on recently implemented European medicines evaluation agency guidelines on comparability of biopharmaceutical proteins. Pharmacotherapy 25: 954-962.
    • (2005) Pharmacotherapy , vol.25 , pp. 954-962
    • Combe, C.1    Tredree, R.L.2    Schellekens, H.3
  • 13
    • 33748921915 scopus 로고    scopus 로고
    • Biophysical comparability of the same protein from different manufacturers: A case study using epoetin alfa from epogen and eprex
    • Deechongkit S, Aoki KH, Park SS, Kerwin BA, (2006). Biophysical comparability of the same protein from different manufacturers: a case study using epoetin alfa from epogen and eprex. J Pharm Sci 95: 1931-1943.
    • (2006) J Pharm Sci , vol.95 , pp. 1931-1943
    • Deechongkit, S.1    Aoki, K.H.2    Park, S.S.3    Kerwin, B.A.4
  • 14
    • 0035833541 scopus 로고    scopus 로고
    • Erythropoietin-mediated neuroprotection involves cross-talk between Jak2 and NF-kB signaling cascades
    • Digicaylioglu M, Lipton SA, (2001). Erythropoietin-mediated neuroprotection involves cross-talk between Jak2 and NF-kB signaling cascades. Nature 412: 641-647.
    • (2001) Nature , vol.412 , pp. 641-647
    • Digicaylioglu, M.1    Lipton, S.A.2
  • 15
    • 0014325267 scopus 로고
    • Reversible blocking of amino groups with citraconic anhydride
    • Dixon HBF, Perham RN, (1968). Reversible blocking of amino groups with citraconic anhydride. Biochem J 109: 312-314.
    • (1968) Biochem J , vol.109 , pp. 312-314
    • Dixon, H.B.F.1    Perham, R.N.2
  • 16
    • 0033590630 scopus 로고    scopus 로고
    • Hydrogen peroxide-induced apoptosis is CD 95-independent, requires the release of mitochondria-derived reactive oxygen species and the activation of NF-kappa B
    • Dumont A, (1999). Hydrogen peroxide-induced apoptosis is CD 95-independent, requires the release of mitochondria-derived reactive oxygen species and the activation of NF-kappa B. Oncogene 18: 747-757.
    • (1999) Oncogene , vol.18 , pp. 747-757
    • Dumont, A.1
  • 17
    • 0015115320 scopus 로고
    • The measurement of amino groups in proteins and peptides
    • Fields R, (1971). The measurement of amino groups in proteins and peptides. Biochem J 124: 581-590.
    • (1971) Biochem J , vol.124 , pp. 581-590
    • Fields, R.1
  • 18
    • 13844320400 scopus 로고    scopus 로고
    • A nonerythropoietic derivative of erythropoietin protects the myocardium from ischemia-reperfusion injury
    • Fiordaliso F, Chimenti S, Staszewsky L, Bai A, Carlo E, Cuccovillo I, et al. (2005). A nonerythropoietic derivative of erythropoietin protects the myocardium from ischemia-reperfusion injury. Proc Natl Acad Sci U S A 102: 2046-2051.
    • (2005) Proc Natl Acad Sci U S A , vol.102 , pp. 2046-2051
    • Fiordaliso, F.1    Chimenti, S.2    Staszewsky, L.3    Bai, A.4    Carlo, E.5    Cuccovillo, I.6
  • 19
    • 0037227316 scopus 로고    scopus 로고
    • Erythropoietin: Physiology and pharmacology update
    • Fisher JW, (2003). Erythropoietin: physiology and pharmacology update. Exp Biol Med 228: 1-14.
    • (2003) Exp Biol Med , vol.228 , pp. 1-14
    • Fisher, J.W.1
  • 20
    • 0027288347 scopus 로고
    • Activation of apoptosis by serum deprivation in a teratocarcinoma cell line: Inhibition by L-acetylcarnitine
    • Galli G, Fratelli M, (1993). Activation of apoptosis by serum deprivation in a teratocarcinoma cell line: inhibition by L-acetylcarnitine. Exp Cell Res 204: 54-60.
    • (1993) Exp Cell Res , vol.204 , pp. 54-60
    • Galli, G.1    Fratelli, M.2
  • 21
    • 3242772957 scopus 로고    scopus 로고
    • EPO and alpha-MSH prevent ischemia/reperfusion-induced down-regulation of AQPs and sodium transporters in rat kidney
    • Gong H, Wang W, Kwon TH, Jonassen T, Li C, Ring T, et al. (2004). EPO and alpha-MSH prevent ischemia/reperfusion-induced down-regulation of AQPs and sodium transporters in rat kidney. Kidney Int 66: 683-695.
    • (2004) Kidney Int , vol.66 , pp. 683-695
    • Gong, H.1    Wang, W.2    Kwon, T.H.3    Jonassen, T.4    Li, C.5    Ring, T.6
  • 22
    • 0037047154 scopus 로고    scopus 로고
    • Recombinant human erythropoietin counteracts secondary injury and markedly enhances neurological recovery from experimental spinal cord trauma
    • Gorio A, Gokmen N, Erbayraktar S, Yilmaz O, Madaschi L, Cichetti C, et al. (2002). Recombinant human erythropoietin counteracts secondary injury and markedly enhances neurological recovery from experimental spinal cord trauma. Proc Natl Acad Sci U S A 99: 9450-9455.
    • (2002) Proc Natl Acad Sci U S A , vol.99 , pp. 9450-9455
    • Gorio, A.1    Gokmen, N.2    Erbayraktar, S.3    Yilmaz, O.4    Madaschi, L.5    Cichetti, C.6
  • 23
    • 0000529593 scopus 로고
    • Molecular structural effects produced in proteins by reaction with succinic anhydride
    • Habeeb AF, Cassidy HG, Singer SG, (1958). Molecular structural effects produced in proteins by reaction with succinic anhydride. Biochem Biophys Acta 29: 587-593.
    • (1958) Biochem Biophys Acta , vol.29 , pp. 587-593
    • Habeeb, A.F.1    Cassidy, H.G.2    Singer, S.G.3
  • 24
    • 0026514620 scopus 로고
    • Carbamylation-induced alterations in low-density lipoprotein mechanism
    • Horkko S, Savolainen MJ, Kervinen K, Kesaniemi YA, (1992). Carbamylation-induced alterations in low-density lipoprotein mechanism. Kidney Int 4: 1175-1181.
    • (1992) Kidney Int , vol.4 , pp. 1175-1181
    • Horkko, S.1    Savolainen, M.J.2    Kervinen, K.3    Kesaniemi, Y.A.4
  • 25
    • 33845979434 scopus 로고    scopus 로고
    • Carbamylated erythropoietin protects the kidney from ischemia-reperfusion injury without stimulating erythropoiesis
    • Imamura R, Isaka Y, Ichimaru N, Takahara S, Okuyama A, (2007). Carbamylated erythropoietin protects the kidney from ischemia-reperfusion injury without stimulating erythropoiesis. Biochem Biophys Res Commun 353: 786-792.
    • (2007) Biochem Biophys Res Commun , vol.353 , pp. 786-792
    • Imamura, R.1    Isaka, Y.2    Ichimaru, N.3    Takahara, S.4    Okuyama, A.5
  • 26
    • 36049007201 scopus 로고    scopus 로고
    • Recombinant EPO production points the nephrologist should know
    • Jelkmann W, (2007). Recombinant EPO production points the nephrologist should know. Nephrol Dial Transplant 22: 2749-2753.
    • (2007) Nephrol Dial Transplant , vol.22 , pp. 2749-2753
    • Jelkmann, W.1
  • 27
    • 58549098542 scopus 로고    scopus 로고
    • 'O', erythropoietin carbamoylation versus carbamylation
    • Jelkmann W, (2008). 'O', erythropoietin carbamoylation versus carbamylation. Nephrol Dial Transplant 23: 3033.
    • (2008) Nephrol Dial Transplant , vol.23 , pp. 3033
    • Jelkmann, W.1
  • 28
    • 7444253390 scopus 로고    scopus 로고
    • Beneficial and ominous aspects of the pleiotropic action of erythropoietin
    • Jelkmann W, Wagner K, (2004). Beneficial and ominous aspects of the pleiotropic action of erythropoietin. Ann Hematol 83: 673-686.
    • (2004) Ann Hematol , vol.83 , pp. 673-686
    • Jelkmann, W.1    Wagner, K.2
  • 29
    • 0036678821 scopus 로고    scopus 로고
    • Erythropoietin administration protects retinal neurons from acute ischemia-reperfusion injury
    • Junk AK, Mammis A, Savitz SI, Singh M, Roth S, Malhotra S, et al. (2002). Erythropoietin administration protects retinal neurons from acute ischemia-reperfusion injury. Proc Natl Acad Sci U S A 99: 10659-10664.
    • (2002) Proc Natl Acad Sci U S A , vol.99 , pp. 10659-10664
    • Junk, A.K.1    Mammis, A.2    Savitz, S.I.3    Singh, M.4    Roth, S.5    Malhotra, S.6
  • 30
    • 33644990074 scopus 로고    scopus 로고
    • Charge modification at multiple C-terminal lysine residues regulates p53 oligomerization and its nucleus-cytoplasm trafficking
    • Kawaguchi Y, Ito A, Appella E, Yao T, (2006). Charge modification at multiple C-terminal lysine residues regulates p53 oligomerization and its nucleus-cytoplasm trafficking. J Biol Chem 281: 1394-1400.
    • (2006) J Biol Chem , vol.281 , pp. 1394-1400
    • Kawaguchi, Y.1    Ito, A.2    Appella, E.3    Yao, T.4
  • 32
    • 0034674703 scopus 로고    scopus 로고
    • Role of peroxiredoxins in regulating intracellular hydrogen peroxide and hydrogen peroxide-induced apoptosis in thyroid cells
    • Kim H, Lee TH, Park ES, Suh JM, Park SJ, Chung HK, et al. (2000). Role of peroxiredoxins in regulating intracellular hydrogen peroxide and hydrogen peroxide-induced apoptosis in thyroid cells. J Biol Chem 275: 18266-18270.
    • (2000) J Biol Chem , vol.275 , pp. 18266-18270
    • Kim, H.1    Lee, T.H.2    Park, E.S.3    Suh, J.M.4    Park, S.J.5    Chung, H.K.6
  • 33
    • 34447118238 scopus 로고    scopus 로고
    • Erythropoietin and carbamylated erythropoietin are neuroprotective following spinal cord hemisection in the rat
    • King VR, Averill SA, Hewazy D, Priestley JV, Torup L, Michael-Titus AT, (2007). Erythropoietin and carbamylated erythropoietin are neuroprotective following spinal cord hemisection in the rat. Eur J Neurosci 26: 90-100.
    • (2007) Eur J Neurosci , vol.26 , pp. 90-100
    • King, V.R.1    Averill, S.A.2    Hewazy, D.3    Priestley, J.V.4    Torup, L.5    Michael-Titus, A.T.6
  • 34
    • 0031755934 scopus 로고    scopus 로고
    • Biological of erythropoietin
    • Lacombe C, Mayeux P, (1998). Biological of erythropoietin. Haematologica 83: 724-732.
    • (1998) Haematologica , vol.83 , pp. 724-732
    • Lacombe, C.1    Mayeux, P.2
  • 35
    • 0032916880 scopus 로고    scopus 로고
    • The molecular biological of erythropoietin
    • Lacombe C, Mayeux P, (1999). The molecular biological of erythropoietin. Nephrol Dial Transplant 14 (Suppl 2): 22-28.
    • (1999) Nephrol Dial Transplant , vol.14 , Issue.SUPPL. 2 , pp. 22-28
    • Lacombe, C.1    Mayeux, P.2
  • 36
    • 3042725549 scopus 로고    scopus 로고
    • Derivatives of erythropoietin that are tissue protective but not erythropoietic
    • Leist M, Ghezzi P, Grasso G, Bianchi R, Villa P, Fratelli M, et al. (2004). Derivatives of erythropoietin that are tissue protective but not erythropoietic. Science 305: 239-242.
    • (2004) Science , vol.305 , pp. 239-242
    • Leist, M.1    Ghezzi, P.2    Grasso, G.3    Bianchi, R.4    Villa, P.5    Fratelli, M.6
  • 37
    • 44449179744 scopus 로고    scopus 로고
    • Salvianolic Acid B Inhibits Hydrogen Peroxide-Induced Endothelial Cell Apoptosis through Regulating PI3K/Akt Signaling
    • Liu CL, Xie LX, Li M, Durairajan SSK, Goto S, Huan JD, (2007). Salvianolic Acid B Inhibits Hydrogen Peroxide-Induced Endothelial Cell Apoptosis through Regulating PI3K/Akt Signaling. Plos ONE 19: e1321.
    • (2007) Plos ONE , vol.19
    • Liu, C.L.1    Xie, L.X.2    Li, M.3    Durairajan, S.S.K.4    Goto, S.5    Huan, J.D.6
  • 38
    • 0010482868 scopus 로고
    • The modification of lysine
    • Lundblad R.L. Noyes C.M. (eds). CRC Press: Boca Raton, FL
    • Lundblad RL, Noyes CM, (1984). The modification of lysine. In:, Lundblad RL, Noyes CM, (eds). Chemical Reagent for Protein Modification. CRC Press: Boca Raton, FL, pp. 127-170.
    • (1984) Chemical Reagent for Protein Modification , pp. 127-170
    • Lundblad, R.L.1    Noyes, C.M.2
  • 39
    • 11244333356 scopus 로고    scopus 로고
    • New avenues of exploration for erythropoietin
    • Maiese K, Li F, Chong ZZ, (2005). New avenues of exploration for erythropoietin. JAMA 293: 90-95.
    • (2005) JAMA , vol.293 , pp. 90-95
    • Maiese, K.1    Li, F.2    Chong, Z.Z.3
  • 42
    • 77954331629 scopus 로고    scopus 로고
    • Guidelines for reportingexperiments involving animals: The ARRIVE guidelines
    • (2010).
    • McGrath J, Drummond G, McLachlan E, Kilkenny C, Wainwright C, (2010). Guidelines for reportingexperiments involving animals: the ARRIVE guidelines. Br J Pharmacol 160: 1573-1576.
    • Br J Pharmacol , vol.160 , pp. 1573-1576
    • McGrath, J.1    Drummond, G.2    McLachlan, E.3    Kilkenny, C.4    Wainwright, C.5
  • 43
    • 34447290901 scopus 로고    scopus 로고
    • The continuous erythropoietin receptor activator affects different pathways of diabetic renal injury
    • Menne J, Park JK, Shushakova N, Mengel M, Meier M, Fliser D, (2007). The continuous erythropoietin receptor activator affects different pathways of diabetic renal injury. J Am Soc Nephrol 18: 2046-2053.
    • (2007) J Am Soc Nephrol , vol.18 , pp. 2046-2053
    • Menne, J.1    Park, J.K.2    Shushakova, N.3    Mengel, M.4    Meier, M.5    Fliser, D.6
  • 44
    • 33750487504 scopus 로고    scopus 로고
    • Nonhematopoietic erythropoietin derivatives prevent motoneuron degeneration in vitro and in vivo
    • Mennini T, De Paola M, Bigini P, Mastrotto C, Fumagalli E, Barbera S, et al. (2006). Nonhematopoietic erythropoietin derivatives prevent motoneuron degeneration in vitro and in vivo. Mol Med 12: 153-160.
    • (2006) Mol Med , vol.12 , pp. 153-160
    • Mennini, T.1    De Paola, M.2    Bigini, P.3    Mastrotto, C.4    Fumagalli, E.5    Barbera, S.6
  • 45
    • 0017125959 scopus 로고
    • N-acetylbenzotriazole as a protein reagent
    • Michèle RR, Charis G, (1976). N-acetylbenzotriazole as a protein reagent. Eur J Biochem 65: 25-33.
    • (1976) Eur J Biochem , vol.65 , pp. 25-33
    • Michèle, R.R.1    Charis, G.2
  • 46
    • 33644775862 scopus 로고    scopus 로고
    • Erythropoietin, modified to not stimulate red blood cell production, retains its cardioprotective properties
    • Moon C, Krawczyk M, Paik D, Coleman T, Brines M, Juhaszova M, et al. (2006). Erythropoietin, modified to not stimulate red blood cell production, retains its cardioprotective properties. J Pharmacol Exp Ther 316: 999-1005.
    • (2006) J Pharmacol Exp Ther , vol.316 , pp. 999-1005
    • Moon, C.1    Krawczyk, M.2    Paik, D.3    Coleman, T.4    Brines, M.5    Juhaszova, M.6
  • 47
    • 0030636320 scopus 로고    scopus 로고
    • Erythropoietin receptor is expressed in rat hippocampal and cerebral cortical neurons, and erythropoietin prevents in vitro glutamate-induced neuronal death
    • Morishita E, Masuda S, Nagao M, Yasuda Y, Sasaki R, (1997). Erythropoietin receptor is expressed in rat hippocampal and cerebral cortical neurons, and erythropoietin prevents in vitro glutamate-induced neuronal death. Neuroscience 76: 105-116.
    • (1997) Neuroscience , vol.76 , pp. 105-116
    • Morishita, E.1    Masuda, S.2    Nagao, M.3    Yasuda, Y.4    Sasaki, R.5
  • 48
    • 0030831330 scopus 로고    scopus 로고
    • Apoptotic cell death in neuronal differentiation of P19 EC cells: Cell death follows reentry into S phase
    • Ninomiya Y, Adams R, Morriss-Kay GM, Eto K, (1997). Apoptotic cell death in neuronal differentiation of P19 EC cells: cell death follows reentry into S phase. J Cell Physiol 172: 25-35.
    • (1997) J Cell Physiol , vol.172 , pp. 25-35
    • Ninomiya, Y.1    Adams, R.2    Morriss-Kay, G.M.3    Eto, K.4
  • 49
    • 33646911359 scopus 로고    scopus 로고
    • Role of parathyroid hormone-related protein in tubulointerstitial apoptosis and fibrosis after folic acid-induced nephrotoxicity
    • Ortega A, Rámila D, Ardura JA, Esteban V, Ruiz-Ortega M, Barat A, et al. (2006). Role of parathyroid hormone-related protein in tubulointerstitial apoptosis and fibrosis after folic acid-induced nephrotoxicity. J Am Soc Nephrol 17: 1594-1603.
    • (2006) J Am Soc Nephrol , vol.17 , pp. 1594-1603
    • Ortega, A.1    Rámila, D.2    Ardura, J.A.3    Esteban, V.4    Ruiz-Ortega, M.5    Barat, A.6
  • 51
    • 4344675279 scopus 로고    scopus 로고
    • Pretreatment with EPO reduces the injury and dysfunction caused by ischemia/reperfusion in the mouse kidney in vivo
    • Patel NS, Sharples EJ, Cuzzocrea S, Chatterjee PK, Britti D, Yaqoob MM, et al. (2004). Pretreatment with EPO reduces the injury and dysfunction caused by ischemia/reperfusion in the mouse kidney in vivo. Kidney Int 66: 983-989.
    • (2004) Kidney Int , vol.66 , pp. 983-989
    • Patel, N.S.1    Sharples, E.J.2    Cuzzocrea, S.3    Chatterjee, P.K.4    Britti, D.5    Yaqoob, M.M.6
  • 52
    • 0028180569 scopus 로고
    • JAK2 associates with the beta c chain of the receptor for granulocyte-macrophage colony-stimulating factor, and its activation requires the membrane-proximal region
    • Quelle FW, Sato N, Witthuhn BA, Inhorn RC, Eder M, Miyajima A, et al. (1994). JAK2 associates with the beta c chain of the receptor for granulocyte-macrophage colony-stimulating factor, and its activation requires the membrane-proximal region. Mol Cell Biol 14: 4335-4341.
    • (1994) Mol Cell Biol , vol.14 , pp. 4335-4341
    • Quelle, F.W.1    Sato, N.2    Witthuhn, B.A.3    Inhorn, R.C.4    Eder, M.5    Miyajima, A.6
  • 53
    • 0014409413 scopus 로고
    • Carbamylation of pepsinogen and pepsin
    • Rimon S, Perlmann G, (1968). Carbamylation of pepsinogen and pepsin. J Biol Chem 243: 3566-3572.
    • (1968) J Biol Chem , vol.243 , pp. 3566-3572
    • Rimon, S.1    Perlmann, G.2
  • 54
    • 0025253474 scopus 로고
    • Chemical modification of erythropoietin: An increase in in vivo activity by guanidination
    • Satake R, Kozutsumi H, Takeuchi M, Asano K, (1990). Chemical modification of erythropoietin: an increase in in vivo activity by guanidination. Biochim Biophys Acta 1038: 125-129.
    • (1990) Biochim Biophys Acta , vol.1038 , pp. 125-129
    • Satake, R.1    Kozutsumi, H.2    Takeuchi, M.3    Asano, K.4
  • 55
    • 32944459736 scopus 로고    scopus 로고
    • Factors influencing the immunogenicity of therapeutic proteins
    • Schellekens H, (2005). Factors influencing the immunogenicity of therapeutic proteins. Nephrol Dial Transplant 20 (Suppl 6): 3-9.
    • (2005) Nephrol Dial Transplant , vol.20 , Issue.SUPPL. 6 , pp. 3-9
    • Schellekens, H.1
  • 56
    • 3543097510 scopus 로고    scopus 로고
    • Erythropoietin protects the kidney against the injury and dysfunction caused by ischemia-reperfusion
    • Sharples EJ, Patel N, Brown P, Stewart K, Mota-Philipe H, Sheaff M, et al. (2004). Erythropoietin protects the kidney against the injury and dysfunction caused by ischemia-reperfusion. J Am Soc Nephrol 15: 2115-2124.
    • (2004) J Am Soc Nephrol , vol.15 , pp. 2115-2124
    • Sharples, E.J.1    Patel, N.2    Brown, P.3    Stewart, K.4    Mota-Philipe, H.5    Sheaff, M.6
  • 60
    • 23744466195 scopus 로고    scopus 로고
    • Interaction of polysorbate 80 with erythropoietin: A case study in protein-surfactant interactions
    • Villalobos AP, Gunturi SR, Heavner GA, (2005). Interaction of polysorbate 80 with erythropoietin: a case study in protein-surfactant interactions. Pharm Res 22: 1186-1194.
    • (2005) Pharm Res , vol.22 , pp. 1186-1194
    • Villalobos, A.P.1    Gunturi, S.R.2    Heavner, G.A.3
  • 61
    • 33748707376 scopus 로고    scopus 로고
    • European regulatory guidelines for biosimilars
    • Wiecek A, Mikhail A, (2006). European regulatory guidelines for biosimilars. Nephrol Dial Transplant 21 (Suppl 5): 17-20.
    • (2006) Nephrol Dial Transplant , vol.21 , Issue.SUPPL. 5 , pp. 17-20
    • Wiecek, A.1    Mikhail, A.2
  • 62
    • 0141595004 scopus 로고    scopus 로고
    • Preconditioning with erythropoietin protects against subsequent ischemia-reperfusion injury in rat kidney
    • Yang CW, Li C, Jung JY, Shin SJ, Choi BS, Lim SW, et al. (2003). Preconditioning with erythropoietin protects against subsequent ischemia-reperfusion injury in rat kidney. FASEB J 17: 1754-1755.
    • (2003) FASEB J , vol.17 , pp. 1754-1755
    • Yang, C.W.1    Li, C.2    Jung, J.Y.3    Shin, S.J.4    Choi, B.S.5    Lim, S.W.6


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.